Trader Note — 8357 total
WEN heads into its August 7 earnings print with short interest climbing again, options traders rotating toward calls, and a stock that clawed back 5.6% on the week — a setup where the bear camp and the calendar are now…
EchoStar reports on August 3 with short sellers still holding a meaningful position — but the six-week cover trade has fundamentally changed the character of that bet. The short-side story is one of retreat, not…
Valmont Industries enters August with an unusual problem: its closest peers are surging while it sits nearly 17% below where it traded a month ago. The stock closed Friday at $481.70, down about 1% on the week and…
Solstice Advanced Materials heads into its August 5 earnings event carrying a short interest position that has nearly tripled in a month — while the stock itself has shed a third of its value over the same period. The…
Paramount Skydance Corporation enters its August 3 earnings report with the stock off 19% over the past month, short sellers still pressing, and options markets notably less hedged than usual — an unusual combination…
Ralliant Corporation enters its August 11 earnings date in an unusual position: the Street just raised targets across the board, yet the stock has fallen 12% in a month and dropped nearly 6% this week alone. The…
BCAX enters its August 12 earnings event in an unusual position: short sellers have been cutting exposure even as the company's own executives took profits at the top. Short interest has dropped sharply — down 6.4% on…
BTC — Grayscale's Bitcoin Mini Trust — enters August with a split personality: down 2% on the week, up 7% over the past month, and carrying almost no short interest at all. The most interesting thing about this product…
Ferguson Enterprises enters its August 10 earnings release with a freshly split analyst community, rising options defensiveness, and short sellers adding to positions — all while the stock trades nearly 20% below the…
Rezolve AI has cleared its August 6 earnings hurdle with the short thesis at its most aggressive in months — yet the stock closed the week up 8.9%, leaving bears in an uncomfortable spot. The positioning picture is…
AGL arrives at its August 5 earnings report having lost 6.5% over the past week and 14.5% over the past month — but options traders are still leaning heavily into the upside story, even as the analyst community remains…
688386 arrives at its August 27 earnings date in an uncomfortable position: the CEO bought the dip last week, but the stock has since fallen further, leaving that bet in the red heading into the next test. The insider…
SIMEPROP is drifting lower while most of its Malaysian property peers push higher — a divergence that sharpens focus on the August 26 earnings release. The peer gap is the clearest tension this week. SIMEPROP closed…
A195870 — HAESUNG DS Co., Ltd. — trades at a striking discount to analyst expectations, with next earnings due in under three weeks and the stock still nursing heavy monthly losses despite Friday's violent bounce. The…
FFM heads into August with two competing forces pulling in opposite directions: a major institutional buyer adding aggressively to its stake, and a short position that — despite easing — remains near its highest level…
The ground ASML clawed back after its Q2 beat is gone. The Amsterdam-listed shares dropped 8.2% on the week to close at €1,434 — reversing most of the recovery that last week's note described as "closing, not…
Samsung Electronics closed July 30 at KRW 191,000 — but the question that now matters is whether the post-earnings re-rating has actually closed the gap, or merely narrowed it. The previous two ORTEX notes framed the…
GSK delivered its Q2 results on July 29 and the post-print picture looks materially different from the cautious setup that preceded it. The most striking data shift this week is the ORTEX short score, which collapsed…
BIOA enters August as one of the week's most dramatic single-stock stories — down 58% in five sessions and 64% in a single day, a collapse that rewrites the entire investment thesis around its lead drug BGE-102. The…
Sirius XM closed out the week at $29.61, down 4.4% on Friday after delivering its Q2 results on July 30 — a reaction that lands squarely in line with the company's recent pattern of selling off after prints. The…
